Related Experiment Video
Updated: Jan 20, 2026

Stress-induced Antibiotic Susceptibility Testing on a Chip
Published on: January 8, 2014
Bad bug, no test: Tigecycline susceptibility testing challenges and way forward
Chaitra Shankar1, Agila Kumari Pragasam1, Balaji Veeraraghavan1
1Department of Clinical Microbiology, Christian Medical College, Vellore, Tamil Nadu, India.
Tigecycline susceptibility testing for resistant bacteria like Klebsiella pneumoniae and Acinetobacter baumannii is challenging. Standardized methods and interpretive criteria are needed for appropriate clinical use of this important reserve antibiotic.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Tigecycline is a critical reserve antibiotic for treating multidrug-resistant (MDR) bacteria, particularly Klebsiella pneumoniae and Acinetobacter baumannii.
- Current tigecycline susceptibility testing methods yield inconsistent results, complicating clinical decision-making.
- There is a significant need for standardized methodologies and interpretive criteria for tigecycline susceptibility testing.
Discussion:
- Inconsistent results from automated antimicrobial susceptibility testing platforms pose a challenge for tigecycline.
- Established European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Food and Drug Administration (FDA) breakpoints vary and are often organism-specific.
- Non-species-related pharmacokinetic/pharmacodynamic (PK/PD) breakpoints, such as those defined by EUCAST, offer a potential solution for K. pneumoniae and A. baumannii.
Key Insights:
- Accurate tigecycline susceptibility testing is crucial for managing infections caused by MDR pathogens.
- Broth microdilution is recommended as an appropriate method for tigecycline susceptibility testing.
- EUCAST PK/PD breakpoints may provide a more consistent approach for tigecycline susceptibility testing in K. pneumoniae and A. baumannii.
Outlook:
- Development of standardized tigecycline susceptibility testing protocols is essential.
- Harmonization of interpretive criteria across different regulatory bodies is needed.
- Further validation of non-species-related PK/PD breakpoints for tigecycline is warranted.
More Related Videos
11:25Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing
Published on: October 15, 2014
12:08Rapid Antimicrobial Susceptibility Testing by Stimulated Raman Scattering Imaging of Deuterium Incorporation in a Single Bacterium
Published on: February 14, 2022
Related Concept Videos
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Susceptibility, Permittivity and Dielectric Constant
Testes: Histology
The spermatogenic cells, responsible for producing sperm, are...
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Testes: Gross Anatomy
Each testis is surrounded by the tunica albuginea, a dense connective tissue layer that provides structural support and protection. This layer is covered by an outer serous membrane called the tunica vaginalis, which helps reduce friction...
Significance Testing: Overview